Literature DB >> 33455581

Endectocides as a complementary intervention in the malaria control program: a systematic review.

Fereshteh Ghahvechi Khaligh1,2, Abbas Jafari3,4, Elena Silivanova5, Mikhail Levchenko5, Bahlol Rahimi6, Saber Gholizadeh7,8.   

Abstract

BACKGROUND: Malaria is the most common vector-borne disease transmitted to humans by Anopheles mosquitoes. Endectocides and especially ivermectin will be available as a vector control tool soon. The current review could be valuable for trial design and clinical studies to control malaria transmission.
METHODS: PubMed/MEDLINE, Scopus, Web of Science, and Science Direct were searched for original English published papers on ("Malaria chemical control" OR "Malaria elimination" OR "Anopheles vector control" OR "Malaria zooprophylaxis") AND ("Systemic insecticides" OR "Endectocides" OR "Ivermectin"). The last search was from 19 June 2019 to 31 December 2019. It was updated on 17 November 2020. Two reviewers (SG and FGK) independently reviewed abstracts and full-text articles. Data were extracted by one person and checked by another. As meta-analyses were not possible, a qualitative summary of results was performed.
RESULTS: Thirty-six published papers have used systemic insecticides/endectocides for mosquito control. Most of the studies (56.75%) were done on Anopheles gambiae complex species on doses from 150 μg/kg to 400 μg/kg in several studies. Target hosts for employing systemic insecticides/drugs were animals (44.2%, including rabbit, cattle, pig, and livestock) and humans (32.35%).
CONCLUSIONS: Laboratory and field studies have highlighted the potential of endectocides in malaria control. Ivermectin and other endectocides could soon serve as novel malaria transmission control tools by reducing the longevity of Anopheles mosquitoes that feed on treated hosts, potentially decreasing Plasmodium parasite transmission when used as mass drug administration (MDA).

Entities:  

Keywords:  Endectocides; Ivermectin; Malaria elimination; Systemic insecticides

Mesh:

Substances:

Year:  2021        PMID: 33455581      PMCID: PMC7812718          DOI: 10.1186/s13643-021-01578-9

Source DB:  PubMed          Journal:  Syst Rev        ISSN: 2046-4053


  40 in total

Review 1.  The global status of insect resistance to neonicotinoid insecticides.

Authors:  Chris Bass; Ian Denholm; Martin S Williamson; Ralf Nauen
Journal:  Pestic Biochem Physiol       Date:  2015-04-28       Impact factor: 3.963

2.  Systemic insecticides used in dogs: potential candidates for phlebotomine vector control?

Authors:  Sonia Ares Gomez; Albert Picado
Journal:  Trop Med Int Health       Date:  2017-04-25       Impact factor: 2.622

3.  Discovery of sarolaner: A novel, orally administered, broad-spectrum, isoxazoline ectoparasiticide for dogs.

Authors:  Tom L McTier; Nathan Chubb; Michael P Curtis; Laura Hedges; Gregory A Inskeep; Christopher S Knauer; Sanjay Menon; Brian Mills; Aleah Pullins; Erich Zinser; Debra J Woods; Patrick Meeus
Journal:  Vet Parasitol       Date:  2016-02-23       Impact factor: 2.738

4.  The Anopheles stephensi odorant binding protein 1 (AsteObp1) gene: a new molecular marker for biological forms diagnosis.

Authors:  S Gholizadeh; S Firooziyan; H Ladonni; H Mohammadzadeh Hajipirloo; N Dinparast Djadid; A Hosseini; A Raz
Journal:  Acta Trop       Date:  2015-03-17       Impact factor: 3.112

Review 5.  Isoxazolines: A Novel Chemotype Highly Effective on Ectoparasites.

Authors:  Tina Weber; Paul M Selzer
Journal:  ChemMedChem       Date:  2016-01-06       Impact factor: 3.466

6.  Molecular phylogenetic analysis of Anopheles and Cellia subgenus anophelines (Diptera: Culicidae) in temperate and tropical regions of Iran.

Authors:  Saber Gholizadeh; Navid Dinparast Djadid; Behzad Nouroozi; Mojtaba Bekmohammadi
Journal:  Acta Trop       Date:  2012-12-01       Impact factor: 3.112

7.  Avermectins, MK-933 and MK-936, for mosquito control.

Authors:  S Pampiglione; G Majori; G Petrangeli; R Romi
Journal:  Trans R Soc Trop Med Hyg       Date:  1985       Impact factor: 2.184

8.  Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial.

Authors:  André Lin Ouédraogo; Guido J H Bastiaens; Alfred B Tiono; Wamdaogo M Guelbéogo; Kevin C Kobylinski; Alphonse Ouédraogo; Aïssata Barry; Edith C Bougouma; Issa Nebie; Maurice San Ouattara; Kjerstin H W Lanke; Lawrence Fleckenstein; Robert W Sauerwein; Hannah C Slater; Thomas S Churcher; Sodiomon B Sirima; Chris Drakeley; Teun Bousema
Journal:  Clin Infect Dis       Date:  2014-11-19       Impact factor: 9.079

9.  Mass drug administration of ivermectin in south-eastern Senegal reduces the survivorship of wild-caught, blood fed malaria vectors.

Authors:  Massamba Sylla; Kevin C Kobylinski; Meg Gray; Phillip L Chapman; Moussa D Sarr; Jason L Rasgon; Brian D Foy
Journal:  Malar J       Date:  2010-12-20       Impact factor: 2.979

10.  Systemic insecticide treatment of the canine reservoir of Trypanosoma cruzi induces high levels of lethality in Triatoma infestans, a principal vector of Chagas disease.

Authors:  Ariel Loza; Adrianna Talaga; Gladys Herbas; Ruben Jair Canaviri; Thalia Cahuasiri; Laura Luck; Alvaro Guibarra; Raquel Goncalves; Juan Antonio Pereira; Sonia A Gomez; Albert Picado; Louisa Alexandra Messenger; Caryn Bern; Orin Courtenay
Journal:  Parasit Vectors       Date:  2017-07-19       Impact factor: 3.876

View more
  1 in total

Review 1.  Ivermectin as an endectocide may boost control of malaria vectors in India and contribute to elimination.

Authors:  Sundus Shafat Ahmad; Manju Rahi; Poonam Saroha; Amit Sharma
Journal:  Parasit Vectors       Date:  2022-01-10       Impact factor: 3.876

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.